OA
LH icon

Oak Associates’s Labcorp LH Stock Holding History

Oak Associates’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.5M Sell
62,607
-375
-0.6% -$98.6K 0.98% 28
2026
Q1 		$16.8M Hold
62,982
– – 1.13% 27
2025
Q4 		$15.8M Sell
62,982
-1,670
-3% -$444K 0.95% 29
2025
Q3 		$18.6M Sell
64,652
-1,700
-3% -$455K 1.13% 27
2025
Q2 		$17.4M Buy
66,352
+2,788
+4% +$679K 1.14% 26
2025
Q1 		$14.8M Buy
63,564
+501
+0.8% +$122K 1.11% 28
2024
Q4 		$14.5M Sell
63,063
-639
-1% -$147K 1% 27
2024
Q3 		$14.2M Buy
63,702
+995
+2% +$219K 0.96% 30
2024
Q2 		$12.8M Sell
62,707
-609
-1% -$124K 0.85% 31
2024
Q1 		$13.8M Sell
63,316
-1,302
-2% -$287K 0.96% 30
2023
Q4 		$14.7M Buy
64,618
+77
+0.1% +$16.2K 1.11% 27
2023
Q3 		$13M Sell
64,541
-10,754
-14% -$2.27M 1.08% 27
2023
Q2 		$15.6M Sell
75,295
-11,993
-14% -$2.33M 1.25% 20
2023
Q1 		$17.2M Buy
87,288
+1
+0% +$206 1.41% 20
2022
Q4 		$17.7M Buy
87,287
+7,061
+9% +$1.38M 1.48% 22
2022
Q3 		$14.1M Sell
80,226
-472
-0.6% -$96.6K 1.2% 27
2022
Q2 		$16.2M Sell
80,698
-30
-0% -$6.39K 1.27% 28
2022
Q1 		$18.3M Sell
80,728
-1,107
-1% -$260K 1.12% 28
2021
Q4 		$22.1M Sell
81,835
-960
-1% -$238K 1.18% 26
2021
Q3 		$20M Hold
82,795
– – 1.14% 27
2021
Q2 		$19.6M Sell
82,795
-472
-0.6% -$108K 1.11% 28
2021
Q1 		$18.2M Buy
83,267
+1,036
+1% +$208K 1.08% 30
2020
Q4 		$14.4M Buy
82,231
+6,175
+8% +$1.07M 0.87% 33
2020
Q3 		$12.3M Sell
76,056
-1,676
-2% -$266K 0.82% 33
2020
Q2 		$11.1M Sell
77,732
-1,269
-2% -$176K 0.74% 39
2020
Q1 		$8.58M Buy
79,001
+1,979
+3% +$285K 0.7% 42
2019
Q4 		$11.2M Sell
77,022
-2,450
-3% -$354K 0.66% 48
2019
Q3 		$11.5M Sell
79,472
-501
-0.6% -$73.1K 0.71% 43
2019
Q2 		$11.9M Buy
+79,973
New +$11.2M 0.74% 40

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Oak Associates's LH Position: Q2 2026 in Review

Oak Associates reduced its Labcorp (LH) stake by 0.6% in Q2 2026, selling an estimated $98.6K and leaving 62,607 shares worth $17.5M. The position accounts for 0.98% of the portfolio, ranked #28.

Oak Associates first reported a position in LH in Q2 2019 and has held it in 29 quarters since. The position peaked at $22.1M in Q4 2021. 1,058 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Oak Associates held 62,607 shares of Labcorp worth $17.5M as of Q2 2026.
  • Oak Associates sold 375 Labcorp shares in Q2 2026, an estimated $98.6K.
  • Labcorp made up 0.98% of Oak Associates's portfolio in Q2 2026, its #28 holding.
  • Oak Associates first reported a position in Labcorp in Q2 2019 and has held it in 29 quarters since.
  • Oak Associates's Labcorp position peaked at $22.1M in Q4 2021.
  • 1,058 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Oak Associates's 13F filing for Q2 2026, filed 14 Aug 2026.